EA200601796A1 - Пиримидиновые производные для лечения аномального клеточного роста - Google Patents

Пиримидиновые производные для лечения аномального клеточного роста

Info

Publication number
EA200601796A1
EA200601796A1 EA200601796A EA200601796A EA200601796A1 EA 200601796 A1 EA200601796 A1 EA 200601796A1 EA 200601796 A EA200601796 A EA 200601796A EA 200601796 A EA200601796 A EA 200601796A EA 200601796 A1 EA200601796 A1 EA 200601796A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
cell growth
pyrimidine derivatives
anomalous cell
mammals
Prior art date
Application number
EA200601796A
Other languages
English (en)
Russian (ru)
Inventor
Майкл Джозеф Луццио
Джон Чарльз Кат
Original Assignee
Пфайзер Продактс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966230&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200601796(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пфайзер Продактс, Инк. filed Critical Пфайзер Продактс, Инк.
Publication of EA200601796A1 publication Critical patent/EA200601796A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EA200601796A 2004-05-14 2005-05-02 Пиримидиновые производные для лечения аномального клеточного роста EA200601796A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57131204P 2004-05-14 2004-05-14
PCT/IB2005/001201 WO2005111023A1 (en) 2004-05-14 2005-05-02 Pyrimidine derivatives for the treatment of abnormal cell growth

Publications (1)

Publication Number Publication Date
EA200601796A1 true EA200601796A1 (ru) 2007-04-27

Family

ID=34966230

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601796A EA200601796A1 (ru) 2004-05-14 2005-05-02 Пиримидиновые производные для лечения аномального клеточного роста

Country Status (27)

Country Link
EP (1) EP1751143A1 (nl)
JP (1) JP4099212B2 (nl)
KR (1) KR100886990B1 (nl)
CN (2) CN1953974A (nl)
AP (1) AP2241A (nl)
AR (1) AR049097A1 (nl)
AU (2) AU2005243397A1 (nl)
BR (1) BRPI0511138A (nl)
CA (1) CA2566707A1 (nl)
CR (1) CR8749A (nl)
EA (1) EA200601796A1 (nl)
EC (1) ECSP066997A (nl)
GE (1) GEP20104875B (nl)
GT (1) GT200500113A (nl)
IL (1) IL178828A0 (nl)
MA (1) MA28583B1 (nl)
MX (1) MXPA06011890A (nl)
NL (2) NL1029045C2 (nl)
NO (1) NO20064576L (nl)
NZ (1) NZ550448A (nl)
PA (1) PA8632601A1 (nl)
PE (1) PE20060240A1 (nl)
TN (1) TNSN06370A1 (nl)
TW (1) TWI303635B (nl)
UY (1) UY28894A1 (nl)
WO (1) WO2005111023A1 (nl)
ZA (1) ZA200608394B (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118544A2 (en) * 2004-05-18 2005-12-15 Rigel Pharmaceuticals, Inc. Cycloalkyl substituted pyrimidinediamine compounds and their uses
US20070032514A1 (en) * 2005-07-01 2007-02-08 Zahn Stephan K 2,4-diamino-pyrimidines as aurora inhibitors
KR101060051B1 (ko) * 2005-12-21 2011-08-29 화이자 프로덕츠 인크. 비정상적인 세포 성장을 치료하기 위한 피리미딘 유도체
KR101132880B1 (ko) * 2007-04-18 2012-06-28 화이자 프로덕츠 인크. 비정상적인 세포 성장의 치료를 위한 술포닐 아미드 유도체
WO2009012421A1 (en) * 2007-07-17 2009-01-22 Rigel Pharmaceuticals, Inc. Cyclic amine substituted pyrimidinediamines as pkc inhibitors
WO2009071535A1 (en) * 2007-12-03 2009-06-11 Boehringer Ingelheim International Gmbh Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
ES2645689T3 (es) * 2008-05-21 2017-12-07 Ariad Pharmaceuticals, Inc. Derivados de fósforo como inhibidores de quinasas
US8410126B2 (en) * 2009-05-29 2013-04-02 Boehringer Ingelheim International Gmbh Pyrimidine inhibitors of PKTK2
US8933227B2 (en) 2009-08-14 2015-01-13 Boehringer Ingelheim International Gmbh Selective synthesis of functionalized pyrimidines
EP2464633A1 (en) 2009-08-14 2012-06-20 Boehringer Ingelheim International GmbH Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
US20120244141A1 (en) 2010-09-28 2012-09-27 Boehringer Ingelheim International Gmbh Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
JPWO2014174745A1 (ja) * 2013-04-26 2017-02-23 国立大学法人京都大学 Eg5阻害剤
CN109608444B (zh) * 2018-11-27 2022-02-11 中国药科大学 含异吲哚啉酮的erk抑制剂及其制备方法与用途
CN111732548B (zh) * 2020-06-11 2022-06-17 浙江大学 N2-氨甲酰芳环-2-氨基嘧啶类衍生物及其医药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721437D0 (en) * 1997-10-10 1997-12-10 Glaxo Group Ltd Heteroaromatic compounds and their use in medicine
AR042586A1 (es) 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
WO2003030909A1 (en) 2001-09-25 2003-04-17 Bayer Pharmaceuticals Corporation 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
UA80767C2 (en) * 2002-12-20 2007-10-25 Pfizer Prod Inc Pyrimidine derivatives for the treatment of abnormal cell growth
AP2385A (en) * 2002-12-20 2012-03-23 Pfizer Prod Inc Pyrimidine derivatives for the treatment of abnormal cell growth.

Also Published As

Publication number Publication date
CN102127058A (zh) 2011-07-20
CR8749A (es) 2006-12-05
AU2009238255A1 (en) 2009-12-03
PE20060240A1 (es) 2006-04-01
ZA200608394B (en) 2008-05-28
NO20064576L (no) 2006-11-07
UY28894A1 (es) 2005-12-30
GT200500113A (es) 2006-01-10
PA8632601A1 (es) 2006-06-02
NL1029045A1 (nl) 2005-11-15
AU2005243397A1 (en) 2005-11-24
AP2241A (en) 2011-06-01
TW200539871A (en) 2005-12-16
NL1031845C2 (nl) 2006-11-23
JP4099212B2 (ja) 2008-06-11
MA28583B1 (fr) 2007-05-02
MXPA06011890A (es) 2006-12-14
NZ550448A (en) 2010-11-26
JP2007537234A (ja) 2007-12-20
EP1751143A1 (en) 2007-02-14
BRPI0511138A (pt) 2007-11-27
CA2566707A1 (en) 2005-11-24
KR20070012477A (ko) 2007-01-25
TNSN06370A1 (fr) 2008-02-22
WO2005111023A1 (en) 2005-11-24
KR100886990B1 (ko) 2009-03-04
TWI303635B (en) 2008-12-01
AR049097A1 (es) 2006-06-28
GEP20104875B (en) 2010-01-11
NL1029045C2 (nl) 2006-06-02
ECSP066997A (es) 2007-02-28
NL1031845A1 (nl) 2006-07-31
IL178828A0 (en) 2007-03-08
AP2006003790A0 (en) 2006-10-31
CN1953974A (zh) 2007-04-25

Similar Documents

Publication Publication Date Title
EA200601796A1 (ru) Пиримидиновые производные для лечения аномального клеточного роста
EA200801287A1 (ru) Пиримидиновые производные для лечения аномального клеточного роста
TW200607801A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
TNSN06074A1 (en) Pyrimidine derivatives for the treatment of abnormal cell growth
TW200612949A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
EA200901250A1 (ru) Сульфониламидные производные для лечения аномального роста клеток
EA200971104A1 (ru) Производные бензимидазола
MXPA06013164A (es) Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal.
EA200701808A1 (ru) Производные тетрагидроиндолона и тетрагидроиндазолона
EA200800172A1 (ru) 2,4-диаминопиримидины как ингибиторы aurora
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
EA200800047A1 (ru) Производные пиримидина
NO20085176L (no) Fenyl substituerte heteroaryl-derivater og andvendelse som anti-tumor agenter
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
ATE543803T1 (de) 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren
ATE518824T1 (de) Substituierte cyclohexylmethyl-derivate
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
MXPA05010440A (es) Amidas del acido isoquinolina-5-sulfonico como inhibidores de la akt (proteina quinasa b).
EA200702375A1 (ru) Производные мочевины, способы их получения и применения
EA200601065A1 (ru) Производные имидазола, способы их получения и применения
WO2007076087A3 (en) 3-aryl-substituted quinazolones, and uses thereof
TW200719889A (en) Amino acid derivatives
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados